2nd World Congress on Heart and Cardiovascular Diseases

  • 09-10 May 2024
  • Grand Mercure Bangkok Atrium, Thailand(Hybrid)

Description

The 2nd World Congress on Heart and Cardiovascular Diseases covers topics such as:

  • Cardio-Oncology
  • Congenital Heart Diseases
  • Cardiovascular Diseases
  • Pediatric Cardiology
  • Interventional Cardiology and Cardiac Imaging
  • Thoracic and Cardiovascular Surgery
  • Heart Devices
  • Women and Fetal Cardiology
  • Molecular Cardiology and Vascular biology
  • Diabetes, Obesity and Stroke
  • Arrhythmias and Sports Cardiology
  • Cardiac Nursing and Critical Cardiology
  • Cardiac Immunology and Bleeding
  • Cardiovascular Pharmacology and toxicology
  • Heart-Diagnosis and Transplant
  • Hypertension and Cardiac Regeneration
  • Geriatric and Veterinary Cardiology
  • Cardiovascular Impact of COVID
  • Cardiovascular Anaesthesiology
  • Current Research in Heart & Cardiology
  • Case Reports on Clinical Cardiology
  • Cardiomyopathies
  • Internal and Emergency Medicine

Venue

  • Grand Mercure Bangkok Atrium , 1880 Phetchaburi Rd, Bang Kapi, Huai Khwang, Bangkok, Thailand

More Details

Prices:
399-799 US Dollar (Estimated)
Exhibition:
Included
Organizer:
Scientex Conferences
Website:
Abstract submission deadline: 29 Feb 2024

Future Events

Important

Please, check "World Congress on Heart and Cardiovascular Diseases" official website for possible changes, before making any traveling arrangements

Event Categories

Health & Medicine: Cardiology

Other Events with Similar Categories

Other Events with Similar Location or Organizer

Featured Conferences & Exhibitions

Articles / News / Press releases

Article content. Press on the above link to close

Introduction

Coronary artery disease (CAD) had been frequently recognized as a risk factor for poor prognosis in COVID-19 patients. Syntax score is an invasive coronary angiographic-based tool that is essentially used to determine the severity of CAD. In this study we aim to investigate the prognostic significance of syntax score for mortality and morbidity among COVID-19 patients

Materials and Methods

In this cross-sectional study we have included patients with confirmed COVID-19 diagnosis who underwent percutaneous coronary intervention (PCI). The CAD complexity were measured by Syntax score base on angiographic records and echocardiographic variables were documented. The laboratory data were obtained from HISS database of the hospital. All patients were followed up during one month after discharge for new cardiovascular events, re-hospitalization, heart failure (HF), stent thrombosis, cerebrovascular accidents, and death.

Results

In one month, 108 patients were included in the study. The mean age was 64.8±11.6 and 74 % were male. In the cox regression model, no association were found between Syntax score and the composite outcomes. In the univariate cox proportional HR model; MPV, LDH and ESR were found to have predictive significance for in-hospital death. AKI was resulted to be significantly associated with re-hospitalization in multivariate analysis.

Conclusion:

The present study did not find significant association between adverse outcomes and syntax score in COVID-19 patients referred for PCI. Acute kidney injury and duration of ICU stay was found to be the main factor predicting re-hospitalization and HF. Future studies are needed to confirm these findings